These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. N-(Aminoalkyl)imide antineoplastic agents. Synthesis and biological activity. Zee-Cheng RK; Cheng CC J Med Chem; 1985 Sep; 28(9):1216-22. PubMed ID: 4032424 [TBL] [Abstract][Full Text] [Related]
3. Structural modification study of mitoxantrone (DHAQ). Chloro-substituted mono- and bis[(aminoalkyl)amino]anthraquinones. Zee-Cheng RK; Mathew AE; Xu PL; Northcutt RV; Cheng CC J Med Chem; 1987 Sep; 30(9):1682-6. PubMed ID: 3625713 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of quinocarcin derivatives: thioalkyl-substituted quinones and hydroquinones. Saito H; Hirata T; Kasai M; Fujimoto K; Ashizawa T; Morimoto M; Sato A J Med Chem; 1991 Jul; 34(7):1959-66. PubMed ID: 2066968 [TBL] [Abstract][Full Text] [Related]
5. Flavone acetic acid: a novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in mice. Plowman J; Narayanan VL; Dykes D; Szarvasi E; Briet P; Yoder OC; Paull KD Cancer Treat Rep; 1986 May; 70(5):631-5. PubMed ID: 3708611 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and cytotoxic activity of acronycine derivatives modified at the pyran ring. Elomri A; Skaltsounis AL; Michel S; Tillequin F; Koch M; Rolland Y; Pierré A; Atassi G Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2165-8. PubMed ID: 8945782 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitumor activity of 4-[p-[bis(2-chloroethyl)amino]phenyl]butyrates. Roehrig GR; Billman JH; Marcec J; Fritz P; Shea F J Pharm Sci; 1980 Oct; 69(10):1232-4. PubMed ID: 7420301 [TBL] [Abstract][Full Text] [Related]
8. QSAR of antineoplastics IV: Hansch analysis of N-(7-indolyl)benzenesulfonamides against KB human nasopharynx carcinoma, colon 38 murine adenocarcinoma and P388 murine leukemia cell lines. Roy K; Pal DK; De AU; Sengupta C Drug Des Discov; 2001; 17(3):199-206. PubMed ID: 11469750 [TBL] [Abstract][Full Text] [Related]
9. Potential antitumor agents. 51. Synthesis and antitumor activity of substituted phenazine-1-carboxamides. Rewcastle GW; Denny WA; Baguley BC J Med Chem; 1987 May; 30(5):843-51. PubMed ID: 3572972 [TBL] [Abstract][Full Text] [Related]
10. 6,9-Bis[(aminoalkyl)amino]benzo[g]isoquinoline-5,10-diones. A novel class of chromophore-modified antitumor anthracene-9,10-diones: synthesis and antitumor evaluations. Krapcho AP; Petry ME; Getahun Z; Landi JJ; Stallman J; Polsenberg JF; Gallagher CE; Maresch MJ; Hacker MP; Giuliani FC J Med Chem; 1994 Mar; 37(6):828-37. PubMed ID: 8145234 [TBL] [Abstract][Full Text] [Related]
11. Toward a rationalization of the sensitizing potency of substituted p-benzoquinones: reaction of nucleophiles with p-benzoquinones. Cremer D; Hausen BM; Schmalle HW J Med Chem; 1987 Sep; 30(9):1678-81. PubMed ID: 3625712 [TBL] [Abstract][Full Text] [Related]
12. Amino-substituted 2-[2'-(dimethylamino)ethyl]-1,2-dihydro-3H- dibenz[de,h]isoquinoline-1,3-diones. Synthesis, antitumor activity, and quantitative structure--activity relationship. Sami SM; Dorr RT; Sólyom AM; Alberts DS; Remers WA J Med Chem; 1995 Mar; 38(6):983-93. PubMed ID: 7699715 [TBL] [Abstract][Full Text] [Related]
13. Quantitative structure-activity relationships in 2,5-bis(1-aziridinyl)-p-benzoquinone derivatives against leukemia L-1210. Yoshimoto M; Miyazawa H; Nakao H; Shinkai K; Arakawa M J Med Chem; 1979 May; 22(5):491-6. PubMed ID: 458799 [TBL] [Abstract][Full Text] [Related]
14. Structural modification study of bis(substituted aminoalkylamino)anthraquinones. An evaluation of the relationship of the [2-[(2-hydroxyethyl)amino]ethyl]amino side chain with antineoplastic activity. Zee-Cheng RK; Podrebarac EG; Menon CS; Cheng CC J Med Chem; 1979 May; 22(5):501-5. PubMed ID: 458801 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of furan, thiophene, and azole bis[(carbamoyloxy)methyl] derivatives as potential antineoplastic agents. Anderson WK; Jones AN J Med Chem; 1984 Dec; 27(12):1559-65. PubMed ID: 6502590 [TBL] [Abstract][Full Text] [Related]
16. A new antitumour agent, batracylin, selected by a preclinical solid tumour model. Atassi G; Dumont P; Kabbe HJ; Yoder O Drugs Exp Clin Res; 1988; 14(9):571-4. PubMed ID: 3229319 [TBL] [Abstract][Full Text] [Related]
17. Interaction of gamma-irradiation with two new antineoplastic agents, aziridinylbenzoquinone (AZQ) and 4'- (acridinylamino)methanesulfon-m-anisidide (AMSA), in murine tumors in vivo. Johnson RK; Wodinsky I; Swiniarski J; Meaney KF; Clement JJ Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1605-9. PubMed ID: 583418 [No Abstract] [Full Text] [Related]
18. Potential central nervous system antitumor agents. Aziridinylbenzoquinones. Chou F; Khan AH; Driscoll JS J Med Chem; 1976 Nov; 19(11):1302-8. PubMed ID: 1003407 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and antitumor evaluations of symmetrically and unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones and 1,4-bis[(aminoalkyl)amino]-5,8-dihydroxyanthracene-9,10-diones. Krapcho AP; Getahun Z; Avery KL; Vargas KJ; Hacker MP; Spinelli S; Pezzoni G; Manzotti C J Med Chem; 1991 Aug; 34(8):2373-80. PubMed ID: 1875336 [TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, Biological Evaluation, and Antioxidant and Cytotoxic Activity of Heteroatom-Substituted 1,4-Naphtho- and Benzoquinones. Deniz NG; Ibis C; Gokmen Z; Stasevych M; Novikov V; Komarovska-Porokhnyavets O; Ozyurek M; Guclu K; Karakas D; Ulukaya E Chem Pharm Bull (Tokyo); 2015; 63(12):1029-39. PubMed ID: 26633024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]